Advanced Cellular Models for Rare Disease Study: Exploring Neural, Muscle and Skeletal Organoids

C Bombieri, A Corsi, E Trabetti, A Ruggiero… - International Journal of …, 2024 - mdpi.com
Organoids are self-organized, three-dimensional structures derived from stem cells that can
mimic the structure and physiology of human organs. Patient-specific induced pluripotent …

[HTML][HTML] TRAPPopathies: Severe Multisystem Disorders Caused by Variants in Genes of the Transport Protein Particle (TRAPP) Complexes

R Hall, V Sawant, J Gu, T Sikora, B Rollo… - International Journal of …, 2024 - mdpi.com
The TRAPP (TRAnsport Protein Particle) protein complex is a multi-subunit complex
involved in vesicular transport between intracellular compartments. The TRAPP complex …

Pathological modeling of glycogen storage disease type III with CRISPR/Cas9 edited human pluripotent stem cells

L Rossiaud, P Fragner, E Barbon, A Gardin… - Frontiers in Cell and …, 2023 - frontiersin.org
Introduction: Glycogen storage disease type III (GSDIII) is a rare genetic disease caused by
mutations in the AGL gene encoding the glycogen debranching enzyme (GDE). The …

Use of induced pluripotent stem cells for regenerative medicine and understanding of cell biology

K Recchia, LV de Figueiredo Pessôa… - Reproduction …, 2024 - CSIRO Publishing
Stem cells are a highly desirable tool for regenerative medicine due to unique
characteristics such as immunomodulation and angiogenesis (multipotent cells) and high …

Induced pluripotent stem cells for modeling physiological and pathological striated muscle complexity

L Caron, S Testa, F Magdinier - Journal of Neuromuscular …, 2023 - content.iospress.com
Neuromuscular disorders (NMDs) are a large group of diseases associated with either
alterations of skeletal muscle fibers, motor neurons or neuromuscular junctions. Most of …

Human iPSCs-derived muscle cells as a new model for investigation of EDMD1 pathogenesis

M Lisowska, M Rowińska, A Suszyńska, C Bearzi… - bioRxiv, 2024 - biorxiv.org
Emery-Dreifuss muscular dystrophy type 1 (EDMD1) is a rare genetic disease caused by
mutations in the EMD gene, which encodes the nuclear envelope protein emerin. Despite …

Galectin-3: a novel biomarker of glycogen storage disease type III

H Lucile, L Rossiaud, Q Miagoux, M Benabides… - 2024 - researchsquare.com
Glycogen storage disease type III (GSDIII) is a rare genetic disorder leading to abnormal
glycogen storage in liver and skeletal muscle. In this study, we conducted a comparative …

[PDF][PDF] РАЗРАБОТКА IN VITRO МОДЕЛИ ДИСФЕРЛИНОПАТИИ ПОСРЕДСТВОМ CRISPR/CAS-ОПОСРЕДОВАННОЙ АКТИВАЦИИ ГЕНА DYSF

АА Шаймарданова, ВВ Соловьева… - …, 2024 - tsitologiya.incras.ru
Для разработки методов генной терапии и геномного редактирования при моногенных
заболеваниях необходимы клеточные модели из тканей человека, полученных …